Therefore, understanding the processes underlying the uptake of PSMA-targeting radioligands in the salivary glands is an important step to prevent or reduce xerostomia after PSMA-TRT [55], particularly with alpha emitters [56]. This evidence concerns the gene FOLH1 and xerostomia.